Tetadex Sulfobutyl Aether Sodium Powder Cas 182410-00-0

Tetadex Sulfobutyl Aether Sodium Powder Cas 182410-00-0

Powder Powdex Sulfobutyl Athadex Powder Cas 182410-00-0 est a CyclodExtrin derivatean et Sina Deli scriptor novum genus pharmaceutical excipients.

Mitte Inquisitionem

depictio producti

Xi'an Deli Biochemical Industry Co., Ltd. Est summus tech coeptis specialiter in investigationis & progressionem, productio & venditionesque de Cyclodextrin et ejus derivationes.

Cum suam de instauratione in August XXVII, MCMXCIX, in comitatu est adhaerens ad qualis consilium de "focusing in accessiones, qualis primus, sincera servitium, nititur ad primum-genus, sincerum, certando pro primo-genus '. Post plus XX annis et labore et progressionem, in comitatu currently habet products Deli Brand Hydroxypropyl Pellentesque, Deli Brand Betadex Sulfobutyl Aethe Sodium Powder Cas 182410-00-0. Et supra products sunt relatus et filed cum FDA.



Tetadex Sulfobutyl Aether Sodium Powder Cas 182410-00-0

[Molecular formula]: c42h70-no35 • (c4h8so3na) n

[Specification]: 500g / peram; 1KG / peram; 10Kg / pera / tympanum; aut ut vestri postulationem

[Category]: Pharmaceutical excipients

[Repono]: sigillum conservationem.

[Period validitatem]: XXXVI mensibus


Powdex Sulfobutyl Athadex Powder Cas 182410-00-0 est sodium salit produci cum Pellentesque Lactone in alkaline conditionibus. Est anion, altus aquam, solutum Retadex inde. Pentium Sulfobutyl Athadex potest esse bene combined cum medicamento moleculis ad formare non-covalent in eo crebris stabilitatem, aqua solubility, et salus medicamento, reducendo eius renum, etc., etc. 



Hot Tags: Powder Powdex Sulfobutyl Athadex Powder 182410-00-0, Suspendisse, Sina, Factory, mole, Free Sample, in Sina, in Stock, Lupum, Buy

Related Categoria

Mitte Inquisitionem

Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept